Skip to main content
. 2021 Jul 24;2:100119. doi: 10.1016/j.sintl.2021.100119

Table 4.

List of nucleic acid-based diagnostic tools developed on the basis of emergency use authorized by FDA [79].

Source Mechanism of Detection Site/antibody Target Time limit Detection ​limit Point of care
Thermo Fisher qReverse transcriptase -PCR Open reading ​frame1ab, ​Nucleoprtein coding gene, ​Surface protein coding-gene >2h 10 copies/microliter no
Roche qReverse transcriptase -PCR Open reading ​frame ​1a >2h 9 copies/microliter no
PerkinElmer qReverse transcriptase -PCR Open reading ​frame ​1 ​ab, ​Nucleoprotein coding gene >2h 0.025 copies/microliter no
Sherlock Bioscience CRISPR ​+ ​LFA Surface protein-coding ​gene, Open reading frame1ab 60 ​min 10-100 copies/microliter yes
Cepheid qReverse transcriptase -PCR Nucleoprotein coding gene, Envelope protein coding-gene 45 ​min 0.25 copies/microliter yes
BioFire qReverse transcriptase -PCR Open reading ​frame 8, ​Open reading ​frame ​1 ​ab 50 ​min 0.33 copies/microliter yes
Mesa Biotech Reverse transcriptase -PCR ​+ ​LFA Nucleoprotein coding gene 30 ​min 200 copies/reaction yes
Abbott Isothermal nucleic acid amplification RNA dependent RNA polymerase-gene 5/13 ​min 0.125 copies/microliter yes
CDC qReverse transcriptase -PCR Nucleoprotein coding gene >2h 3.2 copies/microliter no
Mammoth Bioscience CRISPR ​+ ​LFA Envelope protein-coding gene, Nucleoprtein gene 30 ​min 70-300 copies/microliter yes